Cargando…

Measurement of exhaled nitric oxide and serum surfactant protein D levels for monitoring radiation pneumonitis following thoracic radiotherapy

The present study aimed to examine the role of exhaled nitric oxide (eNO) and serum surfactant protein D (SP-D) level in the determination of radiation pneumonitis (RP) after thoracic radiotherapy (RT). The study included 34 treatments for 33 patients, including 16 three-dimensional conformal and 18...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamazaki, Hideya, Aibe, Norihiro, Nakamura, Satoaki, Sasaki, Naomi, Suzuki, Gen, Yoshida, Ken, Yamada, Kei, Koizumi, Masahiko, Arimoto, Taichiro, Iwasaki, Yoshinobu, Kaneko, Yoshiko, Takayama, Koichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5604141/ https://www.ncbi.nlm.nih.gov/pubmed/28943927 http://dx.doi.org/10.3892/ol.2017.6691

Ejemplares similares

Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of Grade 5 radiation pneumonitis
por: Aibe, Norihiro, et al.
Publicado: (2014)

A surveillance study of patterns of reirradiation practice using external beam radiotherapy in Japan
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Potential Risk of Other-Cause Mortality Due to Long-Term Androgen Deprivation Therapy in Elderly Patients with Clinically Localized Prostate Cancer Treated with Radiotherapy—A Confirmation Study
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Reirradiation for Rare Head and Neck Cancers: Orbit, Auditory Organ, and Salivary Glands
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Radiotherapy for Clinically Localized T3b or T4 Very-High-Risk Prostate Cancer-Role of Dose Escalation Using High-Dose-Rate Brachytherapy Boost or High Dose Intensity Modulated Radiotherapy
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Conventional dose versus dose escalated radiotherapy including high-dose-rate brachytherapy boost for patients with Gleason score 9–10 clinical localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

Potential risk of alpha-glucosidase inhibitor administration in prostate cancer external radiotherapy by exceptional rectal gas production: a case report
por: Nishimura, Takuya, et al.
Publicado: (2014)

Reirradiation for local recurrence of oral, pharyngeal, and laryngeal cancers: a multi-institutional study
por: Yamazaki, Hideya, et al.
Publicado: (2023)

Ultrahypofractionated Radiotherapy versus Conventional to Moderate Hypofractionated Radiotherapy for Clinically Localized Prostate Cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Reirradiation for Nasal Cavity or Paranasal Sinus Tumor—A Multi-Institutional Study
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Comparison of radiation dermatitis between hypofractionated and conventionally fractionated postoperative radiotherapy: objective, longitudinal assessment of skin color
por: Yamazaki, Hideya, et al.
Publicado: (2018)

Radiotherapy for elder patients aged ≥80 with clinically localized prostate cancer – Brachytherapy enhanced late GU toxicity especially in elderly
por: Yamazaki, Hideya, et al.
Publicado: (2020)

Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors
por: Yamazaki, Hideya, et al.
Publicado: (2021)

Effective heart-sparing whole lung irradiation using volumetric modulated arc therapy: a case report
por: Suzuki, Gen, et al.
Publicado: (2019)

Comparison of toxicities between ultrahypofractionated radiotherapy versus brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2022)

High-dose-rate brachytherapy with external beam radiotherapy versus low-dose-rate brachytherapy with or without external beam radiotherapy for clinically localized prostate cancer
por: Yamazaki, Hideya, et al.
Publicado: (2021)

A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer
por: Yoshimura, Akihiro, et al.
Publicado: (2018)

The Feasibility of Omitting Postoperative Radiotherapy in Japanese Patients With Ductal Carcinoma In Situ of Breast Treated With Breast-Conserving Surgery
por: Nakashima, Akihiro, et al.
Publicado: (2023)

＜Editors’ Choice＞ Elective nodal irradiation versus involved field radiotherapy for limited disease small cell lung cancer: a single-institution experience
por: Suzuki, Gen, et al.
Publicado: (2022)

Inhaled and exhaled nitric oxide
por: Thébaud, B., et al.
Publicado: (1999)

Radiotherapy for Elderly Patients Aged ≥75 Years with Clinically Localized Prostate Cancer—Is There a Role of Brachytherapy?
por: Yamazaki, Hideya, et al.
Publicado: (2018)

Transitioning from conventional radiotherapy to intensity-modulated radiotherapy for localized prostate cancer: changing focus from rectal bleeding to detailed quality of life analysis
por: Yamazaki, Hideya, et al.
Publicado: (2014)

Effect of Androgen Deprivation Therapy on Other-Cause of Mortality in Elderly Patients with Clinically Localized Prostate Cancer Treated with Modern Radiotherapy: Is There a Negative Impact?
por: Yamazaki, Hideya, et al.
Publicado: (2019)

Role of Brachytherapy Boost in Clinically Localized Intermediate and High-Risk Prostate Cancer: Lack of Benefit in Patients with Very High-Risk Factors T3b–4 and/or Gleason 9–10
por: Yamazaki, Hideya, et al.
Publicado: (2022)

A Case of Thyroid Papillary Carcinoma: Remarkable Decrease in Multiple Lung Metastases within 40 Years after a Single Administration of Radioiodine without Thyroidectomy and with Later Anaplastic Transformation
por: Okuyama, Chio, et al.
Publicado: (2017)

Phase II Study of S‐1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non‐Small Cell Lung Cancer
por: Chihara, Yusuke, et al.
Publicado: (2019)

Clinical Usefulness of the Platelet-to Lymphocyte Ratio in Patients with Angiosarcoma of the Face and Scalp
por: Suzuki, Gen, et al.
Publicado: (2017)

Radiotherapy for T1N0M0 Esophageal Cancer: Analyses of the Predictive Factors and the Role of Endoscopic Submucosal Dissection in the Local Control
por: Suzuki, Gen, et al.
Publicado: (2018)

Fractional exhaled nitric oxide as a potential biomarker for radiation pneumonitis in patients with non-small cell lung cancer: A pilot study
por: Szejniuk, W.M., et al.
Publicado: (2019)

Increasing rectum–prostate distance using a hydrogel spacer to reduce radiation exposure during proton beam therapy for prostate cancer
por: Narukawa, Tsukasa, et al.
Publicado: (2023)

Exhaled and nasal nitric oxide in laryngectomized patients
por: Kramer, Matthias F, et al.
Publicado: (2010)

Nasal and Exhaled Nitric Oxide in Allergic Rhinitis
por: Lee, Keon Jung, et al.
Publicado: (2012)

Exhaled Nitric Oxide Level in Pharynx Angioedema
por: Moos, Łukasz, et al.
Publicado: (2022)

Exhaled Nitric Oxide and Exhaled Breath Temperature as Potential Biomarkers in Patients with Pulmonary Hypertension
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2018)

Storage conditions for stability of offline measurement of fractional exhaled nitric oxide after collection for epidemiologic research
por: Yoda, Yoshiko, et al.
Publicado: (2012)

Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma–COPD overlap
por: Takayama, Yusuke, et al.
Publicado: (2018)

Reference values for exhaled nitric oxide (reveno) study
por: Olivieri, Mario, et al.
Publicado: (2006)

Exhaled Nitric Oxide is Associated with Allergic Inflammation in Children
por: Choi, Bong Seok, et al.
Publicado: (2011)

Exhaled nitric oxide and clinical phenotypes of childhood asthma
por: Mahut, Bruno, et al.
Publicado: (2011)

Exhaled nitric oxide in diagnosis and management of respiratory diseases
por: Abba, Abdullah A.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_radktmjh5vmk6qgqmpha42thi1